COHELLP: collaborative randomized controlled trial on corticosteroids in HELLP …7thSpace Interactive (press release)The systematic review available in Cochrane Library compared corticosteroid (dexamethasone, betamethasone, or prednisolone) given duri…
Everolimus overcomes trastuzumab resistance in HER2+ early breast cancerOncology Nurse AdvisorSome patients with early breast cancer had a benefit in clinical response rate when everolimus was added to trastuzumab treatment, though the benefit was stat…
|
European Medicines Agency (EMA) Accepts Veloxis’ Marketing Authorization …
Wall Street Journal (press release) For Investor and media contact: John Weinberg, M.D. EVP & Chief Commercial Officer Phone: +1 732 321 3208 Email: jdw@veloxis.com About LCP–Tacro(TM) and tacrolimus Tacrolimus is a leading immunosuppression drug used for the prevention of … |
Inhaled, Systemic Steroids Both OK for Asthma – MedPage TodayMedPage TodayPHILADELPHIA — Children treated with inhaled corticosteroids or systemic steroids for acute asthma attacks appear to do equally well in terms of hospital admission rates and oth…
|
Final STRATO Clinical Study Data Demonstrates Potential for LCP-Tacro™ to …
SYS-CON Media (press release) HORSHOLM, Denmark, May 20, 2013 /PRNewswire/ — Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that data from the STRATO study demonstrates the potential for LCP-Tacro™ to improve tacrolimus-induced tremors in stable kidney … |
|
Final STRATO Clinical Study Data Demonstrates Potential For LCP-Tacro™ To …
Daily Markets (press release) HORSHOLM, Denmark, May 20, 2013 /PRNewswire/ – Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that data from the STRATO study demonstrates the potential for LCP-Tacro™ to improve tacrolimus-induced tremors in stable kidney … |
|
Final STRATO Clinical Study Data Demonstrates Potential for LCP-Tacro™ to …
PR Newswire (press release) HORSHOLM, Denmark, May 20, 2013 /PRNewswire/ — Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that data from the STRATO study demonstrates the potential for LCP-Tacro™ to improve tacrolimus-induced tremors in stable kidney … |
Novartis drug Afinitor extends time without disease progression in women with …pharmabiz.comIt showed that Afinitor (everolimus) tablets in combination with trastuzumab (Herceptin) and vinorelbine significantly extended progression-free survival (PFS…
|
Prednisolone Disturbs Carbohydrate Metabolism
Monthly Prescribing Reference (HealthDay News) – In patients with inflammatory diseases without diabetes, treatment with low-dose prednisolone has deleterious effects on carbohydrate metabolism, according to a study published online May 13 in Diabetes Care. Carolyn J. Petersons … |
|
Novartis drug Afinitor significantly extended time without disease progression …
MarketWatch (press release) Basel, May 17, 2013 – Results of a pivotal Phase III trial in women with HER2 positive (HER2+) advanced breast cancer showed that Afinitor� (everolimus) tablets in combination with trastuzumab (Herceptin�*) and vinorelbine significantly extended … |